Diabetes status was included due to its significant prevalence differences across groups (Table 1, p < 0.01) and its established role as a comorbidity that exacerbates HF through metabolic and vascular pathways, which may intersect with PON1’s antioxidant functions. This evidence concerns the gene PON1 and diabetes mellitus.